The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,390.00
Bid: 2,391.00
Ask: 2,392.00
Change: -34.00 (-1.40%)
Spread: 1.00 (0.042%)
Open: 2,400.00
High: 2,417.00
Low: 2,390.00
Prev. Close: 2,424.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management Board Changes

31 Aug 2017 07:00

RNS Number : 3648P
British American Tobacco PLC
31 August 2017
 

31 August 2017

 

British American Tobacco

Management Board Changes

 

 

Following the successful completion of the acquisition of Reynolds American Inc. ("Reynolds American"), we have decided to simplify our regional structure and to fully integrate our Next Generation Products ("NGPs") business into the core operations of the Group - reflecting the outstanding growth of this part of our business to date and its long term importance to the Group's future.

 

As previously announced, Debra Crew joined the Management Board as President and CEO of Reynolds American with effect from 27 July 2017, reporting directly to the Chief Executive, Nicandro Durante.

 

We are now pleased to announce that Jack Bowles, Regional Director, Asia-Pacific, will be appointed to the newly created role of Chief Operating Officer for the international business, excluding the United States ("COO"), reporting directly to the Chief Executive, with effect from 1 October 2017. Jack joined the Group in 2004 and has been a member of the Management Board since October 2009.

Our regional organisational structure will be simplified to create the following three new regions:

· Americas and Sub-Saharan Africa (including East & Central Africa; West Africa and South Africa)

· Europe and North Africa (including Russia, Ukraine, Caucasus, Central Asia, Belarus, and Turkey)

· Asia-Pacific and Middle East

Regional Director responsibilities, reporting directly to the COO and continuing as members of the Management Board, will be reorganised as follows, with effect from 1 January 2018:

 

Ricardo Oberlander, Regional Director, Americas, will be appointed Regional Director, Americas and Sub-Saharan Africa. Ricardo joined the BAT Group in 1989 and has been a member of the Management Board since January 2013.

 

Tadeu Marroco, Regional Director, Western Europe, will be appointed Regional Director, Europe and North Africa. Tadeu joined British American Tobacco in Brazil over 20 years ago and has been a member of the Management Board since September 2014.

 

Johan Vandermeulen, Regional Director, EEMEA, will be appointed Regional Director, Asia-Pacific and Middle East. Johan has been with the BAT Group for more than 20 years and joined the Management Board in September 2014.

Now that we have built a successful NGP business which is poised for substantial growth, we will be fully integrating NGP into our existing business infrastructure across the Group - both within the functions and the Regions - to leverage the scale and expertise of the whole Group to drive growth in an area that is fast becoming a key part of our mainstream business. Kingsley Wheaton, Managing Director, Next Generation Products, will manage this integration process.

 

Andrew Gray, Director, Marketing, will be appointed Chief Marketing Officer, reporting directly to the Chief Executive, with effect from 1 October 2017. This expanded role combines the areas of Marketing and R&D, (including Innovation and Product Development) across all categories - combustible cigarettes and NGPs. Andrew has been with the BAT Group for 31 years and has been a member of the Management Board for over 9 years.

 

David O'Reilly, Group Scientific and R&D Director, remains a member of the Management Board, and will report to the Chief Marketing Officer under the new structure.

 

This new structure will enable better, more integrated resource allocation and decision making across geographies and categories. It creates a truly global multi category business, with NGPs embedded at its heart, to drive continued long term success.

 

 

 

ENQUIRIES

 

INVESTOR RELATIONS:

PRESS OFFICE:

Mike Nightingale

Rachael Brierley

+44 20 7845 1180

+44 20 7845 1519

Anna Vickerstaff / Joanne Walia

 

+44 20 7845 2888

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASDLFWSFWSEEA
Date   Source Headline
9th Feb 20244:17 pmRNSAnnual Financial Report
8th Feb 202412:15 pmRNSDirector/PDMR Shareholding
8th Feb 20247:00 amRNSFinal Results
6th Feb 202410:10 amRNSDirector/PDMR Shareholding
6th Feb 202410:05 amRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSBoard and Committee Changes
5th Feb 202412:25 pmRNSDirector/PDMR Shareholding
5th Feb 202412:20 pmRNSDirector/PDMR Shareholding
5th Feb 202412:15 pmRNSDirector/PDMR Shareholding
2nd Feb 202412:00 pmRNSBAT and PMI Announce Global Patent Settlement
1st Feb 202412:45 pmRNSTotal Voting Rights
15th Jan 20242:00 pmRNSDirector/PDMR Shareholding
4th Jan 202412:30 pmRNSDirector/PDMR Shareholding
2nd Jan 202411:10 amRNSBlock listing Interim Review
2nd Jan 202410:15 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSBranch Register: Dividend Finalisation Information
11th Dec 202310:35 amRNSHolding(s) in Company
11th Dec 202310:30 amRNSDirector/PDMR Shareholding
7th Dec 20233:30 pmRNSDirector/PDMR Shareholding
7th Dec 20233:30 pmRNSDirector/PDMR Shareholding
6th Dec 20237:55 amRNSPre-Close Trading Update and Strategy Update
6th Dec 20237:00 amRNSPre-Close Trading Update and Strategy Update
4th Dec 202311:30 amRNSTotal Voting Rights
4th Dec 20239:24 amRNSDirectorate Change
24th Nov 20232:30 pmRNSDirector/PDMR Shareholding
13th Nov 20233:00 pmRNSDirector/PDMR Shareholding
13th Nov 20232:15 pmRNSDirector/PDMR Shareholding
8th Nov 20239:55 amRNSDirector/PDMR Shareholding
8th Nov 20239:50 amRNSDirector/PDMR Shareholding
8th Nov 20239:45 amRNSDirector/PDMR Shareholding
2nd Nov 20231:15 pmRNSDirector/PDMR Shareholding
2nd Nov 20237:00 amRNSBAT Appoints Chief Financial Officer
1st Nov 202312:10 pmRNSTotal Voting Rights
13th Oct 20237:00 amRNSBAT Appoints Chief People Officer
5th Oct 20231:00 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSDirectorate Change
2nd Oct 20231:40 pmRNSTotal Voting Rights
26th Sep 20232:40 pmRNSDirector/PDMR Shareholding
18th Sep 20237:00 amRNSBranch Register: Dividend Finalisation Information
14th Sep 20239:00 amRNSRussia business update - sale completed
12th Sep 20233:05 pmRNSDirector/PDMR Shareholding
7th Sep 20231:15 pmRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSRussia business update – agreement signed
1st Sep 202310:30 amRNSTotal Voting Rights
24th Aug 20233:40 pmRNSDirector/PDMR Shareholding
22nd Aug 20234:50 pmRNSDirector/PDMR Shareholding
22nd Aug 20233:50 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:25 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.